AVE – Avecho Biotechnology Ltd

🔒

Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

N/A

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Total Analysts: 0

Company Profile

Avecho Biotechnology Limited is an Australia-based company that develops and commercializes human and animal health products using its drug delivery system Tocopherol Phosphate Mixture (TPM). The Company’s products pipeline includes Weaner Pig Starter TPM premix, Poultry TPM, Dairy TPM, and Veterinary Applications. The Company’s segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Company’s Human Health segment covers delivery of pharmaceutical products through gels, injectables and patches. This segment focuses on the development of patches, including TPM/Oxymorphone, TPM/enhanced, and TPM/Oxycodone. The Company is also developing TPM to enhance feed efficiency and health of livestock. Its TPM products are commercialized under license Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Responses